BIOLASE, Inc. (BIOL)
USD 0.02
(27.39%)
USD 0.02
(27.39%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 11.43 Million USD | -28.02% |
| 2022 | 15.88 Million USD | 22.86% |
| 2021 | 12.92 Million USD | 15.88% |
| 2020 | 11.15 Million USD | 1.47% |
| 2019 | 10.99 Million USD | -10.23% |
| 2018 | 12.24 Million USD | -0.41% |
| 2017 | 12.29 Million USD | -9.06% |
| 2016 | 13.52 Million USD | 7.62% |
| 2015 | 12.56 Million USD | 0.46% |
| 2014 | 12.5 Million USD | 9.93% |
| 2013 | 11.37 Million USD | 2.12% |
| 2012 | 11.14 Million USD | -1.5% |
| 2011 | 11.31 Million USD | 61.9% |
| 2010 | 6.98 Million USD | -11.12% |
| 2009 | 7.86 Million USD | -36.66% |
| 2008 | 12.41 Million USD | 62.71% |
| 2007 | 7.62 Million USD | -1.89% |
| 2006 | 7.77 Million USD | -9.85% |
| 2005 | 8.62 Million USD | 5.42% |
| 2004 | 8.18 Million USD | 118.02% |
| 2003 | 3.75 Million USD | 34.38% |
| 2002 | 2.79 Million USD | 47.96% |
| 2001 | 1.88 Million USD | 54.47% |
| 2000 | 1.22 Million USD | 85.52% |
| 1999 | 658.46 Thousand USD | -65.34% |
| 1998 | 1.9 Million USD | 90.0% |
| 1997 | 1 Million USD | 150.0% |
| 1996 | 400 Thousand USD | 0.0% |
| 1995 | 400 Thousand USD | -33.33% |
| 1994 | 600 Thousand USD | 0.0% |
| 1993 | 600 Thousand USD | -45.45% |
| 1992 | 1.1 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 11.27 Million USD | -1.4% |
| 2024 Q2 | 10.9 Million USD | -3.27% |
| 2023 Q1 | 17.77 Million USD | 11.91% |
| 2023 FY | 11.43 Million USD | -28.02% |
| 2023 Q3 | 13.82 Million USD | 3.71% |
| 2023 Q2 | 13.33 Million USD | -25.01% |
| 2023 Q4 | 11.43 Million USD | -17.3% |
| 2022 Q3 | 16.42 Million USD | -0.88% |
| 2022 Q4 | 15.88 Million USD | -3.31% |
| 2022 FY | 15.88 Million USD | 22.86% |
| 2022 Q1 | 14.61 Million USD | 13.01% |
| 2022 Q2 | 16.57 Million USD | 13.43% |
| 2021 Q1 | 11.87 Million USD | 6.45% |
| 2021 Q2 | 12.71 Million USD | 7.06% |
| 2021 FY | 12.92 Million USD | 15.88% |
| 2021 Q3 | 14.06 Million USD | 10.59% |
| 2021 Q4 | 12.92 Million USD | -8.06% |
| 2020 Q2 | 11.93 Million USD | -2.13% |
| 2020 FY | 11.15 Million USD | 1.47% |
| 2020 Q1 | 12.19 Million USD | 10.89% |
| 2020 Q3 | 12.59 Million USD | 5.53% |
| 2020 Q4 | 11.15 Million USD | -11.4% |
| 2019 Q1 | 12.02 Million USD | -1.84% |
| 2019 Q3 | 11.53 Million USD | -6.46% |
| 2019 Q4 | 10.99 Million USD | -4.7% |
| 2019 FY | 10.99 Million USD | -10.23% |
| 2019 Q2 | 12.33 Million USD | 2.59% |
| 2018 Q3 | 13.42 Million USD | -4.18% |
| 2018 Q1 | 13.4 Million USD | 8.97% |
| 2018 FY | 12.24 Million USD | -0.41% |
| 2018 Q4 | 12.24 Million USD | -8.75% |
| 2018 Q2 | 14 Million USD | 4.53% |
| 2017 Q4 | 12.29 Million USD | -12.79% |
| 2017 FY | 12.29 Million USD | -9.06% |
| 2017 Q1 | 14.69 Million USD | 8.65% |
| 2017 Q2 | 15.19 Million USD | 3.4% |
| 2017 Q3 | 14.1 Million USD | -7.17% |
| 2016 FY | 13.52 Million USD | 7.62% |
| 2016 Q4 | 13.52 Million USD | -0.15% |
| 2016 Q3 | 13.54 Million USD | 20.25% |
| 2016 Q1 | 12.56 Million USD | 0.01% |
| 2016 Q2 | 11.26 Million USD | -10.38% |
| 2015 Q2 | 13.68 Million USD | 3.86% |
| 2015 Q1 | 13.17 Million USD | 5.31% |
| 2015 Q3 | 14.11 Million USD | 3.21% |
| 2015 FY | 12.56 Million USD | 0.46% |
| 2015 Q4 | 12.56 Million USD | -11.0% |
| 2014 Q2 | 11.85 Million USD | -0.34% |
| 2014 Q4 | 12.5 Million USD | 6.01% |
| 2014 Q1 | 11.89 Million USD | 4.51% |
| 2014 FY | 12.5 Million USD | 9.93% |
| 2014 Q3 | 11.79 Million USD | -0.43% |
| 2013 Q3 | 11.74 Million USD | -6.48% |
| 2013 Q2 | 12.55 Million USD | 5.35% |
| 2013 Q1 | 11.92 Million USD | 6.99% |
| 2013 FY | 11.37 Million USD | 2.12% |
| 2013 Q4 | 11.37 Million USD | -3.12% |
| 2012 Q2 | 10.7 Million USD | 3.51% |
| 2012 Q4 | 11.14 Million USD | -0.52% |
| 2012 Q1 | 10.33 Million USD | -8.62% |
| 2012 Q3 | 11.2 Million USD | 4.67% |
| 2012 FY | 11.14 Million USD | -1.5% |
| 2011 FY | 11.31 Million USD | 61.9% |
| 2011 Q2 | 8.02 Million USD | 11.86% |
| 2011 Q1 | 7.17 Million USD | 2.73% |
| 2011 Q3 | 9.82 Million USD | 22.34% |
| 2011 Q4 | 11.31 Million USD | 15.16% |
| 2010 Q4 | 6.98 Million USD | -17.14% |
| 2010 FY | 6.98 Million USD | -11.12% |
| 2010 Q3 | 8.43 Million USD | -9.18% |
| 2010 Q2 | 9.28 Million USD | 10.39% |
| 2010 Q1 | 8.41 Million USD | 6.98% |
| 2009 Q1 | 10.49 Million USD | -15.45% |
| 2009 Q2 | 9 Million USD | -14.17% |
| 2009 Q3 | 9.08 Million USD | 0.91% |
| 2009 Q4 | 7.86 Million USD | -13.5% |
| 2009 FY | 7.86 Million USD | -36.66% |
| 2008 Q2 | 9.34 Million USD | 22.67% |
| 2008 Q1 | 7.61 Million USD | -0.17% |
| 2008 Q4 | 12.41 Million USD | 4.67% |
| 2008 Q3 | 11.85 Million USD | 26.94% |
| 2008 FY | 12.41 Million USD | 62.71% |
| 2007 Q2 | 8.81 Million USD | -0.75% |
| 2007 FY | 7.62 Million USD | -1.89% |
| 2007 Q1 | 8.87 Million USD | 14.21% |
| 2007 Q3 | 10.77 Million USD | 22.27% |
| 2007 Q4 | 7.62 Million USD | -29.21% |
| 2006 Q4 | 7.77 Million USD | 28.14% |
| 2006 Q2 | 6.37 Million USD | -16.63% |
| 2006 FY | 7.77 Million USD | -9.85% |
| 2006 Q3 | 6.06 Million USD | -4.85% |
| 2006 Q1 | 7.64 Million USD | -11.31% |
| 2005 Q1 | 8.83 Million USD | 8.02% |
| 2005 Q4 | 8.62 Million USD | -18.09% |
| 2005 FY | 8.62 Million USD | 5.42% |
| 2005 Q3 | 10.52 Million USD | 2.31% |
| 2005 Q2 | 10.28 Million USD | 16.44% |
| 2004 FY | 8.18 Million USD | 118.02% |
| 2004 Q1 | 4.02 Million USD | 7.2% |
| 2004 Q2 | 5.07 Million USD | 26.26% |
| 2004 Q3 | 7.13 Million USD | 40.45% |
| 2004 Q4 | 8.18 Million USD | 14.69% |
| 2003 FY | 3.75 Million USD | 34.38% |
| 2003 Q4 | 3.75 Million USD | 2.63% |
| 2003 Q3 | 3.65 Million USD | -1.43% |
| 2003 Q2 | 3.7 Million USD | 0.51% |
| 2003 Q1 | 3.69 Million USD | 32.16% |
| 2002 Q4 | 2.79 Million USD | 19.11% |
| 2002 Q3 | 2.34 Million USD | 6.69% |
| 2002 Q1 | 2.23 Million USD | 18.28% |
| 2002 FY | 2.79 Million USD | 47.96% |
| 2002 Q2 | 2.19 Million USD | -1.57% |
| 2001 Q2 | 1.26 Million USD | 33.37% |
| 2001 Q1 | 947.71 Thousand USD | -22.42% |
| 2001 Q4 | 1.88 Million USD | 3.06% |
| 2001 Q3 | 1.83 Million USD | 44.86% |
| 2001 FY | 1.88 Million USD | 54.47% |
| 2000 Q3 | 1.35 Million USD | 44.08% |
| 2000 Q1 | 798.93 Thousand USD | 21.33% |
| 2000 Q2 | 938.75 Thousand USD | 17.5% |
| 2000 Q4 | 1.22 Million USD | -9.68% |
| 2000 FY | 1.22 Million USD | 85.52% |
| 1999 Q3 | 1 Million USD | -37.5% |
| 1999 FY | 658.46 Thousand USD | -65.34% |
| 1999 Q4 | 658.46 Thousand USD | -34.15% |
| 1999 Q1 | 1.7 Million USD | -10.53% |
| 1999 Q2 | 1.6 Million USD | -5.88% |
| 1998 Q2 | 1.7 Million USD | 21.43% |
| 1998 Q1 | 1.4 Million USD | 40.0% |
| 1998 FY | 1.9 Million USD | 90.0% |
| 1998 Q3 | 2.1 Million USD | 23.53% |
| 1998 Q4 | 1.9 Million USD | -9.52% |
| 1997 Q1 | 500 Thousand USD | 25.0% |
| 1997 FY | 1 Million USD | 150.0% |
| 1997 Q2 | 500 Thousand USD | 0.0% |
| 1997 Q3 | 500 Thousand USD | 0.0% |
| 1997 Q4 | 1 Million USD | 100.0% |
| 1996 Q4 | 400 Thousand USD | 0.0% |
| 1996 Q3 | 400 Thousand USD | -20.0% |
| 1996 Q2 | 500 Thousand USD | 0.0% |
| 1996 FY | 400 Thousand USD | 0.0% |
| 1996 Q1 | 500 Thousand USD | 25.0% |
| 1995 Q2 | 500 Thousand USD | -16.67% |
| 1995 Q1 | 600 Thousand USD | 0.0% |
| 1995 Q3 | 300 Thousand USD | -40.0% |
| 1995 Q4 | 400 Thousand USD | 33.33% |
| 1995 FY | 400 Thousand USD | -33.33% |
| 1994 Q2 | 300 Thousand USD | 0.0% |
| 1994 Q4 | 600 Thousand USD | 20.0% |
| 1994 FY | 600 Thousand USD | 0.0% |
| 1994 Q3 | 500 Thousand USD | 66.67% |
| 1993 Q1 | 1.2 Million USD | 9.09% |
| 1993 Q2 | 1.2 Million USD | 0.0% |
| 1993 Q3 | 1.1 Million USD | -8.33% |
| 1993 FY | 600 Thousand USD | -45.45% |
| 1993 Q4 | 600 Thousand USD | -45.45% |
| 1992 Q4 | 1.1 Million USD | -47.62% |
| 1992 FY | 1.1 Million USD | 0.0% |
| 1992 Q2 | 1.7 Million USD | 0.0% |
| 1992 Q3 | 2.1 Million USD | 23.53% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -245.408% |
| BrainsWay Ltd. | 3.71 Million USD | -207.587% |
| Cerus Corporation | 39.86 Million USD | 71.323% |
| Envoy Medical, Inc. | 1.4 Million USD | -714.316% |
| electroCore, Inc. | 2.16 Million USD | -429.306% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -2401.751% |
| IceCure Medical Ltd | 2.27 Million USD | -402.549% |
| Inogen, Inc. | 21.84 Million USD | 47.651% |
| OrthoPediatrics Corp. | 105.85 Million USD | 89.199% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -4012.59% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -1143299900.0% |
| MaxCyte, Inc. | 12.22 Million USD | 6.509% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -562.135% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -7209.168% |
| Orthofix Medical Inc. | 222.16 Million USD | 94.854% |
| PAVmed Inc | 1.01 Million USD | -1024.19% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 42.723% |
| RxSight, Inc. | 17.42 Million USD | 34.372% |
| Sight Sciences, Inc. | 7.84 Million USD | -45.662% |
| SI-BONE, Inc. | 20.24 Million USD | 43.538% |
| TELA Bio, Inc. | 13.16 Million USD | 13.136% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 60.906% |
| Vivos Therapeutics, Inc. | 1.00 USD | -1143299900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -167.251% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -4870.87% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -385.272% |
| CVRx, Inc. | 10.98 Million USD | -4.097% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -2830.967% |
| Bioventus Inc. | 91.33 Million USD | 87.482% |
| Venus Concept Inc. | 28.67 Million USD | 60.13% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -349.234% |
| LivaNova PLC | 147.88 Million USD | 92.269% |
| 908 Devices Inc. | 14.93 Million USD | 23.464% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 91.645% |
| Nemaura Medical Inc. | 1.75 Million USD | -551.508% |
| NeuroPace, Inc. | 11.21 Million USD | -1.953% |
| LENSAR, Inc. | 15.68 Million USD | 27.127% |
| Apyx Medical Corporation | 9.92 Million USD | -15.217% |
| Cutera, Inc. | 72.1 Million USD | 84.143% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -327.722% |
| BioSig Technologies, Inc. | -103 Thousand USD | 11200.0% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 75.352% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | -44.52% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 97.066% |
| Axonics, Inc. | 79.94 Million USD | 85.698% |
| Outset Medical, Inc. | 49.21 Million USD | 76.769% |
| IRIDEX Corporation | 9.9 Million USD | -15.415% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 71.242% |
| IRadimed Corporation | 12.82 Million USD | 10.827% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -1412.302% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -4222.381% |
| Telesis Bio, Inc. | 4.02 Million USD | -184.05% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -148.31% |
| Varex Imaging Corporation | 277.5 Million USD | 95.88% |
| Quipt Home Medical Corp. | 18.32 Million USD | 37.612% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 31.715% |
| Dynatronics Corporation | 5.59 Million USD | -104.381% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -205.613% |
| Semler Scientific, Inc. | 445 Thousand USD | -2469.213% |
| InMode Ltd. | 45.09 Million USD | 74.647% |
| Bruker Corporation | 968.3 Million USD | 98.819% |
| Cytosorbents Corporation | 3.68 Million USD | -210.668% |
| DexCom, Inc. | 559.6 Million USD | 97.957% |
| Align Technology, Inc. | 296.9 Million USD | 96.149% |
| Viveve Medical, Inc. | 1.47 Million USD | -676.698% |
| ZimVie Inc. | 79.6 Million USD | 85.637% |
| Movano Inc. | 1.51 Million USD | -655.651% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 81.22% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -7209.168% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 92.761% |
| Profound Medical Corp. | 6.95 Million USD | -64.427% |
| Insulet Corporation | 402.6 Million USD | 97.16% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 22.953% |
| iCAD, Inc. | 917 Thousand USD | -1146.783% |
| Nuwellis, Inc. | 1.99 Million USD | -472.509% |
| Biotricity, Inc. | 1.87 Million USD | -508.332% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 18.178% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -442.877% |
| PAVmed Inc. | 1.01 Million USD | -1024.19% |
| Beyond Air, Inc. | 2.12 Million USD | -437.518% |
| FONAR Corporation | 2.71 Million USD | -321.037% |
| AxoGen, Inc. | 23.02 Million USD | 50.334% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 49.248% |
| Inari Medical, Inc. | 42.9 Million USD | 73.35% |
| UFP Technologies, Inc. | 70.19 Million USD | 83.712% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -1717.13% |
| Tenon Medical, Inc. | 554 Thousand USD | -1963.718% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -586.78% |
| AdaptHealth Corp. | 113.64 Million USD | 89.939% |
| Sintx Technologies, Inc. | 888 Thousand USD | -1187.5% |
| NanoVibronix, Inc. | 2.73 Million USD | -318.485% |
| Quanterix Corporation | 22.36 Million USD | 48.88% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 22.995% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 79.827% |
| TransMedics Group, Inc. | 44.23 Million USD | 74.154% |
| ReWalk Robotics Ltd. | 5.65 Million USD | -102.247% |
| NeuroMetrix, Inc. | 1.55 Million USD | -633.153% |
| Hyperfine, Inc. | 6.58 Million USD | -73.701% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 85.698% |
| Biomerica, Inc. | 2.37 Million USD | -381.187% |
| Bone Biologics Corporation | -328.84 Thousand USD | 3576.725% |
| AVITA Medical, Inc. | 3.12 Million USD | -266.277% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 61.732% |